Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036701318> ?p ?o ?g. }
- W2036701318 endingPage "399" @default.
- W2036701318 startingPage "394" @default.
- W2036701318 abstract "ObjectiveAlthough drug-eluting balloons (DEBs) have shown promising results treating de novo (DN) atherosclerotic lesions and appear to have been widely adopted in Europe, their long-term efficacy in the broad spectrum of femoropopliteal restenosis (RE) remains to be proven. The purpose of the study was to assess the efficacy of paclitaxel-DEBs in restenotic (stented and nonstented) vs DN stenotic femoropopliteal arteries.MethodsThe study prospectively enrolled 100 patients undergoing femoropopliteal endovascular intervention by DEB for RE or DN stenosis. Patients who received additive atherectomy were excluded. The primary end point was the primary patency (PP) rate at 12 months. Secondary end points were sustained clinical improvement and clinically driven target lesion revascularization.ResultsDEBs were used to treat 105 limbs for intermittent claudication (82 [78%]) or critical limb ischemia (23 [22%]) in 100 patients. Of these, 111 lesions were DN stenosis (46 [41%]) or RE (65 [59%]). The overall PP was 86% at 6 months and 74% at 12 months. PP of DN stenosis was higher at 6 months (93% vs 81%) and was significantly (P = .021) better than RE at 12 months (85% vs 68%). Sustained clinical improvement based on Rutherford classification was significant in both groups (P < .001). Target lesion revascularization was significantly lower in DN stenosis compared with RE at 12 months (15% vs 32%; P = .021).ConclusionsDEB angioplasty is an effective therapy for DN femoropopliteal lesions. The results of DEB angioplasty for RE are inferior compared with DN stenosis after 12 months. Nevertheless, results of DEB angioplasty for RE seem comparable with technically more demanding literature-derived strategies. Although drug-eluting balloons (DEBs) have shown promising results treating de novo (DN) atherosclerotic lesions and appear to have been widely adopted in Europe, their long-term efficacy in the broad spectrum of femoropopliteal restenosis (RE) remains to be proven. The purpose of the study was to assess the efficacy of paclitaxel-DEBs in restenotic (stented and nonstented) vs DN stenotic femoropopliteal arteries. The study prospectively enrolled 100 patients undergoing femoropopliteal endovascular intervention by DEB for RE or DN stenosis. Patients who received additive atherectomy were excluded. The primary end point was the primary patency (PP) rate at 12 months. Secondary end points were sustained clinical improvement and clinically driven target lesion revascularization. DEBs were used to treat 105 limbs for intermittent claudication (82 [78%]) or critical limb ischemia (23 [22%]) in 100 patients. Of these, 111 lesions were DN stenosis (46 [41%]) or RE (65 [59%]). The overall PP was 86% at 6 months and 74% at 12 months. PP of DN stenosis was higher at 6 months (93% vs 81%) and was significantly (P = .021) better than RE at 12 months (85% vs 68%). Sustained clinical improvement based on Rutherford classification was significant in both groups (P < .001). Target lesion revascularization was significantly lower in DN stenosis compared with RE at 12 months (15% vs 32%; P = .021). DEB angioplasty is an effective therapy for DN femoropopliteal lesions. The results of DEB angioplasty for RE are inferior compared with DN stenosis after 12 months. Nevertheless, results of DEB angioplasty for RE seem comparable with technically more demanding literature-derived strategies." @default.
- W2036701318 created "2016-06-24" @default.
- W2036701318 creator A5001321618 @default.
- W2036701318 creator A5009379317 @default.
- W2036701318 creator A5027593751 @default.
- W2036701318 creator A5029898297 @default.
- W2036701318 creator A5077373726 @default.
- W2036701318 creator A5086199323 @default.
- W2036701318 date "2015-02-01" @default.
- W2036701318 modified "2023-09-28" @default.
- W2036701318 title "Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis" @default.
- W2036701318 cites W122961614 @default.
- W2036701318 cites W123390893 @default.
- W2036701318 cites W1522445824 @default.
- W2036701318 cites W1904330368 @default.
- W2036701318 cites W193147492 @default.
- W2036701318 cites W1952671373 @default.
- W2036701318 cites W1982669079 @default.
- W2036701318 cites W1997648269 @default.
- W2036701318 cites W1999359428 @default.
- W2036701318 cites W2001908434 @default.
- W2036701318 cites W2006094873 @default.
- W2036701318 cites W2008850799 @default.
- W2036701318 cites W2009999175 @default.
- W2036701318 cites W2026190702 @default.
- W2036701318 cites W2029749879 @default.
- W2036701318 cites W2032905737 @default.
- W2036701318 cites W2036313045 @default.
- W2036701318 cites W2077636289 @default.
- W2036701318 cites W2079069762 @default.
- W2036701318 cites W2085996722 @default.
- W2036701318 cites W2099225 @default.
- W2036701318 cites W2107933809 @default.
- W2036701318 cites W2110578456 @default.
- W2036701318 cites W2116106173 @default.
- W2036701318 cites W2116595255 @default.
- W2036701318 cites W2125683205 @default.
- W2036701318 cites W2132880199 @default.
- W2036701318 cites W2152606085 @default.
- W2036701318 cites W2154938802 @default.
- W2036701318 cites W2168405636 @default.
- W2036701318 cites W2333358463 @default.
- W2036701318 cites W2887033821 @default.
- W2036701318 cites W53209728 @default.
- W2036701318 cites W6367513 @default.
- W2036701318 doi "https://doi.org/10.1016/j.jvs.2014.08.005" @default.
- W2036701318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25307133" @default.
- W2036701318 hasPublicationYear "2015" @default.
- W2036701318 type Work @default.
- W2036701318 sameAs 2036701318 @default.
- W2036701318 citedByCount "19" @default.
- W2036701318 countsByYear W20367013182015 @default.
- W2036701318 countsByYear W20367013182016 @default.
- W2036701318 countsByYear W20367013182017 @default.
- W2036701318 countsByYear W20367013182018 @default.
- W2036701318 countsByYear W20367013182019 @default.
- W2036701318 countsByYear W20367013182020 @default.
- W2036701318 countsByYear W20367013182021 @default.
- W2036701318 countsByYear W20367013182023 @default.
- W2036701318 crossrefType "journal-article" @default.
- W2036701318 hasAuthorship W2036701318A5001321618 @default.
- W2036701318 hasAuthorship W2036701318A5009379317 @default.
- W2036701318 hasAuthorship W2036701318A5027593751 @default.
- W2036701318 hasAuthorship W2036701318A5029898297 @default.
- W2036701318 hasAuthorship W2036701318A5077373726 @default.
- W2036701318 hasAuthorship W2036701318A5086199323 @default.
- W2036701318 hasBestOaLocation W20367013181 @default.
- W2036701318 hasConcept C126322002 @default.
- W2036701318 hasConcept C126838900 @default.
- W2036701318 hasConcept C141071460 @default.
- W2036701318 hasConcept C203092338 @default.
- W2036701318 hasConcept C2776268601 @default.
- W2036701318 hasConcept C2777209855 @default.
- W2036701318 hasConcept C2777466421 @default.
- W2036701318 hasConcept C2778283817 @default.
- W2036701318 hasConcept C2778583881 @default.
- W2036701318 hasConcept C2778963770 @default.
- W2036701318 hasConcept C2779464278 @default.
- W2036701318 hasConcept C2780007028 @default.
- W2036701318 hasConcept C2780326628 @default.
- W2036701318 hasConcept C2780400711 @default.
- W2036701318 hasConcept C2781156865 @default.
- W2036701318 hasConcept C2781464078 @default.
- W2036701318 hasConcept C3018348675 @default.
- W2036701318 hasConcept C500558357 @default.
- W2036701318 hasConcept C535046627 @default.
- W2036701318 hasConcept C71924100 @default.
- W2036701318 hasConceptScore W2036701318C126322002 @default.
- W2036701318 hasConceptScore W2036701318C126838900 @default.
- W2036701318 hasConceptScore W2036701318C141071460 @default.
- W2036701318 hasConceptScore W2036701318C203092338 @default.
- W2036701318 hasConceptScore W2036701318C2776268601 @default.
- W2036701318 hasConceptScore W2036701318C2777209855 @default.
- W2036701318 hasConceptScore W2036701318C2777466421 @default.
- W2036701318 hasConceptScore W2036701318C2778283817 @default.
- W2036701318 hasConceptScore W2036701318C2778583881 @default.
- W2036701318 hasConceptScore W2036701318C2778963770 @default.
- W2036701318 hasConceptScore W2036701318C2779464278 @default.